Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

2013 San Antonio Breast Cancer Symposium (SABCS)

9 - 11 Dec 2013

Henry B. Gonzalez Convention Center, San Antonio, Texas, United States of America

Symptom management and quality of life in metastatic breast cancer

Dr Polly Niravath - Baylor College of Medicine, Houston, Texas

Symptom management and quality of life in metastatic breast cancer ( Dr Polly Niravath - Baylor College of Medicine, Houston, Texas )

The impact of biological age on breast cancer

Dr Alistair Ring - Brighton and Sussex Medical School, UK

The impact of biological age on breast cancer ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )

Aspirin trialled for breast cancer recurrence prevention

Dr Alistair Ring - Brighton and Sussex Medical School, UK

Aspirin trialled for breast cancer recurrence prevention ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )

Oncotype DX: changing breast cancer treatment

Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA

Oncotype DX: changing breast cancer treatment ( Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA )

Drop in breast cancer mortality in developed countries varies

Dr Donald Berry - MD Anderson Cancer Center, Houston, USA

Drop in breast cancer mortality in developed countries varies ( Dr Donald Berry - MD Anderson Cancer Center, Houston, USA )

Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer

Dr Barbara Fowble - University of California, San Francisco, USA

Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer ( Dr Barbara Fowble - University of California, San Francisco, USA )

Translational studies of CDK and PARP inhibitors

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA

Translational studies of CDK and PARP inhibitors ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )

HER2 positive breast cancer treatment, past and future

Dr Edith Perez - Mayo Clinic, Rochester, USA

HER2 positive breast cancer treatment, past and future ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Preventing metastases by tackling exosomes

Dr Jeff Wrana - University of Toronto, Canada

Preventing metastases by tackling exosomes ( Dr Jeff Wrana - University of Toronto, Canada )

Moving breast cancer stem cell therapies to the clinic

Dr Max Wicha - University of Michigan, Ann Arbor, USA

Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )

Breast cancer psychosocial and survivorship issues: are we doing better?

Dr Lesley Fallowfield - University of Sussex, Brighton, UK

Breast cancer psychosocial and survivorship issues: are we doing better? ( Dr Lesley Fallowfield - University of Sussex, Brighton, UK )

Male breast cancer: Opportunities for increased research funding and clinical trial access

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

Male breast cancer: Opportunities for increased research funding and clinical trial access ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy

Dr Sibylle Loibl - German Breast Cancer Group

PIK3CA mutation predicts resistance to anti-HER2 treatment and chemotherapy ( Dr Sibylle Loibl - German Breast Cancer Group )

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Prof Adrian Harris - University of Oxford, Oxford, UK

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy ( Prof Adrian Harris - University of Oxford, Oxford, UK )

Adjuvant bisphosphonate therapy in breast cancer

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria

Adjuvant bisphosphonate therapy in breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )

Pain relief in breast cancer patients in Vietnam

Johnny Nguyen - University of Toronto, Canada

Pain relief in breast cancer patients in Vietnam ( Johnny Nguyen - University of Toronto, Canada )

Careers in translational research

Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA

Careers in translational research ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )

Long term use of aromatase inhibitors and compliance

Prof Peter Barrett-Lee - Cardiff University, UK

Long term use of aromatase inhibitors and compliance ( Prof Peter Barrett-Lee - Cardiff University, UK )

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant ( Prof Sibylle Loibl - German Breast Group, Neu-Isenburg, Germany )

Exercise improves drug-associated joint pain in breast cancer survivors

Prof Melinda Irwin - Yale Cancer Center, New Haven, USA

Exercise improves drug-associated joint pain in breast cancer survivors ( Prof Melinda Irwin - Yale Cancer Center, New Haven, USA )

Benefit of breast cancer screening more consistent across studies than previously understood

Dr Robert Smith - American Cancer Society, Atlanta, USA

Benefit of breast cancer screening more consistent across studies than previously understood ( Dr Robert Smith - American Cancer Society, Atlanta, USA )

Avoiding radiotherapy is an option for some older patients with breast cancer

Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK

Avoiding radiotherapy is an option for some older patients with breast cancer ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )

Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy

Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India.

Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy ( Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India. )

Comment on HER2 research: NeoALTTO trial, BETH study and immune cell levels predicting outcomes

Dr Jennifer Litton - MD Anderson Cancer Center, Houston, USA

Comment on HER2 research: NeoALTTO trial, BETH study and immune cell levels predicting outcomes ( Dr Jennifer Litton - MD Anderson Cancer Center, Houston, USA )

NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival

Prof Martine Piccart-Gebhart - Jules Bordet Institute, Brussels, Belgium

NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival ( Prof Martine Piccart-Gebhart - Jules Bordet Institute, Brussels, Belgium )

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab ( Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

BETH study: highly effective treatment option for patients with HER2 breast cancer

Dr Dennis Slamon - University of California, Los Angeles

BETH study: highly effective treatment option for patients with HER2 breast cancer ( Dr Dennis Slamon - University of California, Los Angeles )

Screening mammography, over diagnosis and over treatment

Dr Gilbert Welch - Dartmouth College, Hanover, USA

Screening mammography, over diagnosis and over treatment ( Dr Gilbert Welch - Dartmouth College, Hanover, USA )

More from ecancer